Back to results
US 2021/0330863 A1Published application
5-hydroxytryptamine 1b receptor-stimulating agent for enhancing in vivo engraftment potential
AssigneesInstitut Pasteur, Universite Paris Descartes, Centre Hospitalier Sainte Anne Paris
InventorsFabrice Bruno CHRETIEN, Raphael GAILLARD, Pierre ROCHETEAU
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of regenerative medicine, and more particularly to the improvement of the in vivo engraftment potential of biological material to be administered to a subject in need thereof.
Claims18
A method for enhancing the in vivo engraftment potential of a biological material, comprising at least the step of in vitro and/or ex vivo contacting an isolated biological material with at least one 5-hydroxytryptamine 1B receptor (5-HT1 BR)-stimulating agent.
Dependencies are inferred from the claim text.